Maternal pre-eclampsia as a risk factor for necrotizing enterocolitis

References

• ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002;77:67–5
   PubMed Web of Science ®Google Scholar
• Cetinkaya M, Ozkan H, Köksal N, et al. Neonatal outcomes of premature infants born to preeclamptic mothers. J Matern-Fetal Neonatal Med 2010;23:425–30
   PubMed Web of Science ®Google Scholar
• Ersch J, Baenziger O, Bernet V, Bucher HU. Feeding problems in preterm infants of preeclamptic mothers. J Paediatr Child Health 2008;44:651–5
   PubMed Web of Science ®Google Scholar
• Eskenazi B, Fenster L, Sidney S, Elkin EP. Fetal growth retardation in infants of multiparous and nulliparous women with preeclampsia. Am J Obstet Gynecol 1993;169:1112–18
   PubMed Web of Science ®Google Scholar
• Shapiro-Mendoza CK, Tomashek KM, Kotelchuck M, et al. Effect of late-preterm birth and maternal medical conditions on newborn morbidity risk. Pediatrics 2008;121:e223–32
   PubMed Web of Science ®Google Scholar
• Wu CS, Nohr EA, Bech BH, et al. Health of children born to mothers who had preeclampsia: a population-based cohort study. Am J Obstet Gynecol 2009;201:269.e1–10
   PubMed Web of Science ®Google Scholar
• Clements KM, Barfield WD, Ayadi MF, Wilber N. Preterm birth-associated cost of early intervention services: an analysis by gestational age. Pediatrics 2007;119:e866–74
   PubMed Web of Science ®Google Scholar
• Cetinkaya M, Ozkan H, Koksal N. Maternal preeclampsia is associated with increased risk of necrotizing enterocolitis in preterm infants. Early Hum Dev 2012;88:893–8
   PubMed Web of Science ®Google Scholar
• Bashiri A, Zmora E, Sheiner E, et al. Maternal hypertensive disorders are an independent risk factor for the development of necrotizing enterocolitis in very low birth weight infants. Fetal Diagn Ther 2003;18:404–7
   PubMed Web of Science ®Google Scholar
• Llanos AR, Moss ME, Pinzòn MC, et al. Epidemiology of neonatal necrotising enterocolitis: a population-based study. Paediatr Perinat Epidemiol 2002;16:342–9
   PubMed Web of Science ®Google Scholar
• Patel BK, Shah JS. Necrotizing enterocolitis in very low birth weight infants: a systemic review. ISRN Gastroenterol 2012;2012:562–94
   Google Scholar
• Horbar JD, Carpenter JH, Badger GJ, et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics 2012;129:1019–26
   PubMed Web of Science ®Google Scholar
• Rüegger C, Hegglin M, Adams M, et al. Population based trends in mortality, morbidity and treatment for very preterm- and very low birth weight infants over 12 years. BMC Pediatr 2012;12:17
   PubMed Web of Science ®Google Scholar
• Holman RC, Stoll BJ, Curns AT, et al. Necrotising enterocolitis hospitalisations among neonates in the United States. Paediatr Perinat Epidemiol 2006;20:498–506
   PubMed Web of Science ®Google Scholar
• Weitkamp J-H, Koyama T, Rock MT, et al. Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. Gut 2013;62:73–82
   PubMed Web of Science ®Google Scholar
• Steinborn A, Schmitt E, Kisielewicz A, et al. Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs. Clin Exp Immunol 2012;167:84–98
   PubMed Web of Science ®Google Scholar
• Peleg D, Kennedy CM, Hunter SK. Intrauterine growth restriction: identification and management. Am Fam Physician 1998;58:453–60, 466–7
   PubMed Web of Science ®Google Scholar
• Sargent IL, Borzychowski AM, Redman CWG. Immunoregulation in normal pregnancy and pre-eclampsia: an overview. Reprod Biomed Online 2006;13:680–6
   PubMed Web of Science ®Google Scholar
• Ashur-Fabian O, Yerushalmi GM, Mazaki-Tovi S, et al. Cell free expression of hif1α and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction. PLoS One 2012;7:e37273
   PubMed Web of Science ®Google Scholar
• Tal R. The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biol Reprod 2012;87:134
   PubMed Web of Science ®Google Scholar
• Shi LZ, Wang R, Huang G, et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 2011;208:1367–76
   PubMed Web of Science ®Google Scholar
• Santner-Nanan B, Peek MJ, Khanam R, et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol Baltim Md 1950 2009;183:7023–30
   Google Scholar
• Prins JR, Boelens HM, Heimweg J, et al. Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertens Pregnancy 2009;28:300–11
   PubMed Web of Science ®Google Scholar
• Darmochwal-Kolarz D, Saito S, Tabarkiewicz J, et al. Apoptosis signaling is altered in CD4+ CD25+ FoxP3+ T regulatory lymphocytes in pre-eclampsia. Int J Mol Sci 2012;13:6548–60
   PubMed Web of Science ®Google Scholar
• Lee SK, Kim JY, Lee M, et al. Th17 and regulatory T cells in women with recurrent pregnancy loss. Am J Reprod Immunol 2012;67:311–18
   PubMed Web of Science ®Google Scholar
• Toldi G, Saito S, Shima T, et al. The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25-FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia. Am J Reprod Immunol 2012;68:175–80
   PubMed Web of Science ®Google Scholar
• Myatt L. Role of placenta in preeclampsia. Endocrine 2002;19:103–11
   PubMed Web of Science ®Google Scholar
• Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 2005;46:1243–9
   PubMed Web of Science ®Google Scholar
• Weitkamp J-H, Rudzinski E, Koyama T, et al. Ontogeny of FOXP3(+) regulatory T cells in the postnatal human small intestinal and large intestinal lamina propria. Pediatr Dev Pathol 2009;12:443–9
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay D, Weaver L, Tobin R, et al. Intrauterine growth restriction and prematurity influence regulatory T cell development in newborns. J Pediatr Surg 2014;49:727–32
   PubMed Web of Science ®Google Scholar